SciClone Pharmaceuticals, Inc.Foster City, CA United States
Company Description
This SciClone won't take you to Oz, but it has taken its drugs to China. The drug firm's flagship product Zadaxin is approved to treat hepatitis B in some 30 countries, including China, its primary market. Zadaxin also has uses in additional viral vaccines and cancer treatments. The drug has yet to receive the regulatory green light, however, in the world's two largest drug markets -- the US and the European Union (EU). SciClone is working with development partner Sigma-Tau to gain marketing approval in the US and EU; the company also wants to expand the use of the drug to include additional conditions. In the meantime, SciClone is seeking to commercialize additional products in the core Chinese market.
| 950 Tower Lane, Ste. 900 | Phone: 650-358-3456 | http://www.sciclone.com |
| Foster City, CA 94404 | Fax: 650-358-3469 | 
Map This Company |
| United States | Toll Free: 800-724-2566 |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
SciClone Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
Executives
| 24 executives listed for SciClone Pharmaceuticals, Inc.'s Foster City, CA location. | ||
| Chairman | Jon Saxe | |
|---|---|---|
| President, CEO, and Director | Friedhelm Blobel | |
| SVP and CFO | GaryTitus | |
Financials
| Company Type | Public - NASDAQ: SCLN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 875 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on SciClone Pharmaceuticals, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
